Romanowicz Lech, Gogiel Tomasz, Galewska Zofia, Bruczko Marta, Bączyk Justyna, Roszkowska-Jakimiec Wiesława, Sobolewski Krzysztof
Department of Medical Biochemistry, Medical University of Białystok, Białystok, Poland.
Department of Medical Biochemistry, Medical University of Białystok, Białystok, Poland.
Eur J Obstet Gynecol Reprod Biol. 2018 Dec;231:48-53. doi: 10.1016/j.ejogrb.2018.10.024. Epub 2018 Oct 9.
Preeclampsia is the most common disorder associated with pregnancy. Our earlier findings revealed a substantial increase in the amount of matrix metalloproteinase-26 (matrilysin 2; MMP-26) in preeclamptic umbilical cord blood. The role of MMP-26 in preeclamptic umbilical cord tissue has not been fully elucidated. Some reports have indicated that the expression of matrilysin 2 and tissue inhibitor of matrix metalloproteinase 4 (TIMP-4) is coordinately regulated during progression of various diseases.
Therefore, we decided to assess the expression and activity of MMP-26 and TIMP-4 in normal and preeclamptic umbilical cord tissues - umbilical cord arteries (UCA), vein (UCV) and Wharton's jelly (WJ). Tissues obtained from 10 normal (control material) and 10 preeclamptic umbilical cords were assessed using immunoenzymatic assay, Western immunoblotting, reverse transcriptase - polymerase chain reaction and fluorometric determination of the enzyme activity.
All umbilical cord tissues, both control and preeclamptic, expressed MMP-26 and TIMP-4 in macromolecular complexes. Preeclampsia induced a significant increase in the content and actual activity of MMP-26 in UCV and WJ, as compared to control. The content of TIMP-4 in preeclamptic UCV and WJ was reduced. The content of MMP-26 mRNA was lower in UCA and UCV, whereas higher in WJ in preeclampsia.
Divergent changes in MMP-26 mRNA and protein expression suggest a difference in the factors controlling the matrilysin synthesis in healthy and preeclamptic subjects. The decrease in TIMP-4 content in preeclamptic UCV might be the main reason for significantly higher actual activity of MMP-26 in that tissue. Only in preeclamptic Wharton's jelly the changes were compatible in terms of the content and activity of MMP-26 and TIMP-4. It cannot be excluded that similar alterations can be observed for the whole vascular system of newborns delivered by mothers with preeclampsia.
子痫前期是与妊娠相关的最常见疾病。我们早期的研究结果显示,子痫前期脐带血中基质金属蛋白酶-26(溶基质素2;MMP-26)的含量大幅增加。MMP-26在子痫前期脐带组织中的作用尚未完全阐明。一些报告表明,在各种疾病进展过程中,溶基质素2和基质金属蛋白酶组织抑制剂4(TIMP-4)的表达受到协同调节。
因此,我们决定评估正常和子痫前期脐带组织——脐动脉(UCA)、静脉(UCV)和华通胶(WJ)中MMP-26和TIMP-4的表达及活性。使用免疫酶测定、Western免疫印迹、逆转录-聚合酶链反应以及酶活性的荧光测定法,对取自10条正常(对照材料)和10条子痫前期脐带的组织进行评估。
对照和子痫前期的所有脐带组织在大分子复合物中均表达MMP-26和TIMP-4。与对照相比,子痫前期导致UCV和WJ中MMP-26的含量和实际活性显著增加。子痫前期UCV和WJ中TIMP-4的含量降低。子痫前期UCA和UCV中MMP-26 mRNA的含量较低,而WJ中的含量较高。
MMP-26 mRNA和蛋白质表达的不同变化表明,健康和子痫前期受试者中控制溶基质素合成的因素存在差异。子痫前期UCV中TIMP-4含量的降低可能是该组织中MMP-26实际活性显著更高的主要原因。仅在子痫前期的华通胶中,MMP-26和TIMP-4的含量及活性变化是一致的。不能排除在子痫前期母亲所生新生儿的整个血管系统中也能观察到类似变化。